Systemic immune activation shapes stroke outcome

Molecular and Cellular Neuroscience

Volumn 53, Issue , 2013, Pages 14-25

  Murray, Katie N ^a   Buggey, Hannah F ^a   Denes, Adam ^a   Allan, Stuart M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cerebral ischaemia; Cytokine; Infection; Inflammation; Neuronal injury; Systemic

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; CD40 ANTIGEN; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; L SELECTIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ASTROCYTE; BLOOD VESSEL INJURY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DEGENERATIVE DISEASE; DIFFUSION WEIGHTED IMAGING; DISEASE PREDISPOSITION; HUMAN; IMMUNE RESPONSE; INFECTION; ISCHEMIC PRECONDITIONING; LEUKOCYTE; LEUKOCYTE ACTIVATION; MENTAL STRESS; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NEUTROPHIL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THROMBOEMBOLISM; VASCULITIS;

EID: 84873280477     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2012.09.004     Document Type: Article

References (194)

1. Abboud H., Labreuche J., Plouin F., Amarenco P., Investigators G. High blood pressure in early acute stroke: a sign of a poor outcome?. J. Hypertens. 2006, 24:381-386.
2. Afek A., Kogan E., Maysel-Auslender S., Mor A., Regev E., Rubinstein A., Keren G., George J. Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice. Microvasc. Res. 2009, 77:364-369.
3. Afshar-Kharghan V., Thiagarajan P. Leukocyte adhesion and thrombosis. Curr. Opin. Hematol. 2006, 13:34-39.
4. Akopov S.E., Simonian N.A., Grigorian G.S. Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke 1996, 27:1739-1743.
5. Al-Bannawi A., Al-Wesebai K., Taha S., Bakhiet M. Chlamydia pneumoniae induces chemokine expression by platelets in patients with atherosclerosis. Med. Princ. Pract. 2011, 20:438-443.
6. Alexander M.R., Moehle C.W., Johnson J.L., Yang Z., Lee J.K., Jackson C.L., Owens G.K. Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. J. Clin. Invest. 2012, 122:70-79.
7. Allen C.L., Bayraktutan U. Risk factors for ischaemic stroke. Int. J. Stroke 2008, 3:105-116.
8. Anderson C.S., Huang Y., Wang J.G., Arima H., Neal B., Peng B., Heeley E., Skulina C., Parsons M.W., Kim J.S., et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008, 7:391-399.
9. Andjelkovic A.V., Stamatovic S.M., Keep R.F. The protective effects of preconditioning on cerebral endothelial cells in vitro. J. Cereb. Blood Flow Metab. 2003, 23:1348-1355.
10. Anlar O., Tombul T., Unal O., Kayan M. Seasonal and environmental temperature variation in the occurrence of ischemic strokes and intracerebral hemorrhages in a Turkish adult population. Int. J. Neurosci. 2002, 112:959-963.
11. Arcaro G., Zamboni M., Rossi L., Turcato E., Covi G., Armellini F., Bosello O., Lechi A. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int. J. Obes. Relat. Metab. Disord. 1999, 23:936-942.
12. Bacon K.B., Premack B.A., Gardner P., Schall T.J. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 1995, 269:1727-1730.
13. Barbarroja N., López-Pedrera R., Mayas M.D., García-Fuentes E., Garrido-Sánchez L., Macías-González M., El Bekay R., Vidal-Puig A., Tinahones F.J. The obese healthy paradox: is inflammation the answer?. Biochem. J. 2010, 430:141-149.
14. Barone F.C., Feuerstein G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 1999, 19:819-834.
15. Barone F.C., Schmidt D.B., Hillegass L.M., Price W.J., White R.F., Feuerstein G.Z., Clark R.K., Lee E.V., Griswold D.E., Sarau H.M. Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia. Stroke 1992, 23:1337-1347. (discussion 1347-1338).
16. Bartholomäus I., Kawakami N., Odoardi F., Schläger C., Miljkovic D., Ellwart J.W., Klinkert W.E., Flügel-Koch C., Issekutz T.B., Wekerle H., et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 2009, 462:94-98.
17. Barton M., Baretella O., Meyer M.R. Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction. Br. J. Pharmacol. 2012, 165:591-602.
18. Bhaskar V., Yin J., Mirza A.M., Phan D., Vanegas S., Issafras H., Michelson K., Hunter J.J., Kantak S.S. Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in apolipoprotein E-deficient mice. Atherosclerosis 2011, 216:313-320.
19. Blann A.D., Tse W., Maxwell S.J., Waite M.A. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J. Hypertens. 1994, 12:925-928.
20. Bordet R., Deplanque D., Maboudou P., Puisieux F., Pu Q., Robin E., Martin A., Bastide M., Leys D., Lhermitte M., et al. Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance. J. Cereb. Blood Flow Metab. 2000, 20:1190-1196.
21. Braunersreuther V., Steffens S., Arnaud C., Pelli G., Burger F., Proudfoot A., Mach F. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1090-1096.
22. Brott T., Thalinger K., Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke 1986, 17:1078-1083.
23. Bulbulia R., Bowman L., Wallendszus K., Parish S., Armitage J., Peto R., Collins R. Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5years in 20,536 high-risk individuals: a randomised controlled trial. Lancet 2011, 378:2013-2020. Group, H.P.S.C.
24. Buraczynska K., Luchowski P., Wojczal J., Ksiazek A., Stelmasiak Z. Monocyte chemoattractant protein (MCP-1) A-2518G gene polymorphism in stroke patients with different comorbidities. Clin. Biochem. 2010, 43:1421-1426.
25. Calbo E., Alsina M., Rodríguez-Carballeira M., Lite J., Garau J. The impact of time on the systemic inflammatory response in pneumococcal pneumonia. Eur. Respir. J. 2010, 35:614-618.
26. Canouï-Poitrine F., Luc G., Mallat Z., Machez E., Bingham A., Ferrieres J., Ruidavets J.B., Montaye M., Yarnell J., Haas B., et al. Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology 2011, 77:1165-1173.
27. Cao Y.J., Wang Y.M., Zhang J., Zeng Y.J., Liu C.F. The effects of antiplatelet agents on platelet-leukocyte aggregations in patients with acute cerebral infarction. J. Thromb. Thrombolysis 2009, 27:233-238.
28. Caso J.R., Lizasoain I., Lorenzo P., Moro M.A., Leza J.C. The role of tumor necrosis factor-alpha in stress-induced worsening of cerebral ischemia in rats. Neuroscience 2006, 142:59-69.
29. Caso J.R., Moro M.A., Lorenzo P., Lizasoain I., Leza J.C. Involvement of IL-1beta in acute stress-induced worsening of cerebral ischaemia in rats. Eur. Neuropsychopharmacol. 2007, 17:600-607.
30. Cesari M., Penninx B.W., Newman A.B., Kritchevsky S.B., Nicklas B.J., Sutton-Tyrrell K., Rubin S.M., Ding J., Simonsick E.M., Harris T.B., et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003, 108:2317-2322.
31. Chen J., Simon R. Ischemic tolerance in the brain. Neurology 1997, 48:306-311.
32. Chen H., Chopp M., Zhang R.L., Bodzin G., Chen Q., Rusche J.R., Todd R.F. Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann. Neurol. 1994, 35:458-463.
33. Clayton T.C., Thompson M., Meade T.W. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur. Heart J. 2008, 29:96-103.
34. Connolly E.S., Winfree C.J., Springer T.A., Naka Y., Liao H., Yan S.D., Stern D.M., Solomon R.A., Gutierrez-Ramos J.C., Pinsky D.J. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 1996, 97:209-216.
35. Cowperthwaite M.C., Burnett M.G. An analysis of admissions from 155 United States hospitals to determine the influence of weather on stroke incidence. J. Clin. Neurosci. 2011, 18:618-623.
36. Coyle P. Outcomes to middle cerebral artery occlusion in hypertensive and normotensive rats. Hypertension 1984, 6:I69-I74.
37. Cremonini F., Gabrielli M., Gasbarrini G., Pola P., Gasbarrini A. The relationship between chronic H. pylori infection, CagA seropositivity and stroke: meta-analysis. Atherosclerosis 2004, 173:253-259.
38. Cunningham C., Wilcockson D.C., Campion S., Lunnon K., Perry V.H. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 2005, 25:9275-9284.
39. Cunningham C., Campion S., Lunnon K., Murray C.L., Woods J.F., Deacon R.M., Rawlins J.N., Perry V.H. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol. Psychiatry 2009, 65:304-312.
40. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., Davis V., Gutierrez-Ramos J.C., Connelly P.W., Milstone D.S. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 2001, 107:1255-1262.
41. Dawson J., Quinn T., Walters M.R. Under the weather with stroke; more data emerge. Int. J. Stroke 2009, 4:19-20.
42. de Jager S.C., Kraaijeveld A.O., Grauss R.W., de Jager W., Liem S.S., van der Hoeven B.L., Prakken B.J., Putter H., van Berkel T.J., Atsma D.E., et al. CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events. J. Mol. Cell. Cardiol. 2008, 45:446-452.
43. Deb P., Sharma S., Hassan K.M. Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology 2010, 17:197-218.
44. del Zoppo G.J., Schmid-Schönbein G.W., Mori E., Copeland B.R., Chang C.M. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991, 22:1276-1283.
45. Denes A., Vidyasagar R., Feng J., Narvainen J., McColl B.W., Kauppinen R.A., Allan S.M. Proliferating resident microglia after focal cerebral ischaemia in mice. J. Cereb. Blood Flow Metab. 2007, 27:1941-1953.
46. Dénes A., Humphreys N., Lane T.E., Grencis R., Rothwell N. Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice. J. Neurosci. 2010, 30:10086-10095.
47. Denes A., Pinteaux E., Rothwell N.J., Allan S.M. Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic target. Cerebrovasc. Dis. 2011, 32:517-527.
48. Dénes A., Ferenczi S., Kovács K.J. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood-brain barrier damage and brain oedema independently of infarct size. J. Neuroinflammation 2011, 8:164.
49. Denes A., Drake C., Stordy J., Chamberlain J., McColl B., Gram H., Crossman D., Francis S., Allan S.M., Rothwell N.J. Interleukin-1 mediates neuroinflammatory changes associated with diet-induced atherosclerosis. J. Am. Heart Assoc. 2012, 2012:1. 10.1161/JAHA.112.002006.
50. DeSouza C.A., Dengel D.R., Macko R.F., Cox K., Seals D.R. Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension. Am. J. Hypertens. 1997, 10:1335-1341.
51. Di Napoli M., Schwaninger M., Cappelli R., Ceccarelli E., Di Gianfilippo G., Donati C., Emsley H.C., Forconi S., Hopkins S.J., Masotti L., et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 2005, 36:1316-1329.
52. Dirnagl U., Simon R.P., Hallenbeck J.M. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 2003, 26:248-254.
53. Dirnagl U., Becker K., Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 2009, 8:398-412.
54. Doodes P.D., Cao Y., Hamel K.M., Wang Y., Rodeghero R.L., Kobezda T., Finnegan A. CCR5 is involved in resolution of inflammation in proteoglycan-induced arthritis. Arthritis Rheum. 2009, 60:2945-2953.
55. Drake C., Boutin H., Jones M.S., Denes A., McColl B.W., Selvarajah J.R., Hulme S., Georgiou R.F., Hinz R., Gerhard A., et al. Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav Immun. 2011, Aug 25(6):1113-1122. (Epub 2011 Feb 26).
56. Drexler H., Zeiher A.M. Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia. Hypertension 1991, 18:II90-II99.
57. Duan S.Z., Usher M.G., Mortensen R.M. PPARs: the vasculature, inflammation and hypertension. Curr. Opin. Nephrol. Hypertens. 2009, 18:128-133.
58. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., Abela G.S., Franchi L., Nuñez G., Schnurr M., et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
59. Emsley H.C., Hopkins S.J. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol. 2008, 7:341-353.
60. Ferro D., Loffredo L., Polimeni L., Fimognari F., Villari P., Pignatelli P., Fuster V., Violi F. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2763-2768.
61. Ferroni P., Basili S., Falco A., Davì G. Platelet activation in type 2 diabetes mellitus. J. Thromb. Haemost. 2004, 2:1282-1291.
62. Fischer F.R., Luo Y., Luo M., Santambrogio L., Dorf M.E. RANTES-induced chemokine cascade in dendritic cells. J. Immunol. 2001, 167:1637-1643.
63. Fisher M., Feuerstein G., Howells D.W., Hurn P.D., Kent T.A., Savitz S.I., Lo E.H., Group S. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009, 40:2244-2250.
64. Fotis L., Agrogiannis G., Vlachos I.S., Pantopoulou A., Margoni A., Kostaki M., Verikokos C., Tzivras D., Mikhailidis D.P., Perrea D. Intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 at the early stages of atherosclerosis in a rat model. In Vivo 2012, 26:243-250.
65. Frostegård J., Ulfgren A.K., Nyberg P., Hedin U., Swedenborg J., Andersson U., Hansson G.K. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999, 145:33-43.
66. Galea J., Armstrong J., Gadsdon P., Holden H., Francis S.E., Holt C.M. Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. Arterioscler. Thromb. Vasc. Biol. 1996, 16:1000-1006.
67. Gautier E.L., Jakubzick C., Randolph G.J. Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1412-1418.
68. Gawaz M., Langer H., May A.E. Platelets in inflammation and atherogenesis. J. Clin. Invest. 2005, 115:3378-3384.
69. Gesuete R., Orsini F., Zanier E.R., Albani D., Deli M.A., Bazzoni G., De Simoni M.G. Glial cells drive preconditioning-induced blood-brain barrier protection. Stroke 2011, 42:1445-1453.
70. Gill R., Kemp J.A., Sabin C., Pepys M.B. Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats. J. Cereb. Blood Flow Metab. 2004, 24:1214-1218.
71. Gkaliagkousi E., Corrigall V., Becker S., de Winter P., Shah A., Zamboulis C., Ritter J., Ferro A. Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension. Eur. Heart J. 2009, 30:3048-3054.
72. Granger D.N., Rodrigues S.F., Yildirim A., Senchenkova E.Y. Microvascular responses to cardiovascular risk factors. Microcirculation 2010, 17:192-205.
73. Grau A.J., Buggle F., Heindl S., Steichen-Wiehn C., Banerjee T., Maiwald M., Rohlfs M., Suhr H., Fiehn W., Becher H. Recent infection as a risk factor for cerebrovascular ischemia. Stroke 1995, 26:373-379.
74. Grau A.J., Buggle F., Steichen-Wiehn C., Heindl S., Banerjee T., Seitz R., Winter R., Forsting M., Werle E., Bode C. Clinical and biochemical analysis in infection-associated stroke. Stroke 1995, 26:1520-1526.
75. Grau A.J., Boddy A.W., Dukovic D.A., Buggle F., Lichy C., Brandt T., Hacke W., Investigators C. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004, 35:1147-1152.
76. Grau A.J., Fischer B., Barth C., Ling P., Lichy C., Buggle F. Influenza vaccination is associated with a reduced risk of stroke. Stroke 2005, 36:1501-1506.
77. Grau A.J., Urbanek C., Palm F. Common infections and the risk of stroke. Nat. Rev. Neurol. 2010, 6:681-694.
78. Gruetter C.A., Barry B.K., McNamara D.B., Gruetter D.Y., Kadowitz P.J., Ignarro L. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J. Cyclic Nucleotide Res. 1979, 5:211-224.
79. Hamer M., Batty G.D., Stamatakis E., Kivimaki M. Comparison of risk factors for fatal stroke and ischemic heart disease: a prospective follow up of the health survey for England. Atherosclerosis 2011, 219:807-810.
80. Hankey G.J. Potential new risk factors for ischemic stroke: what is their potential?. Stroke 2006, 37:2181-2188.
81. Haramaki N., Ikeda H., Takenaka K., Katoh A., Sugano R., Yamagishi S., Matsuoka H., Imaizumi T. Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1471-1477.
82. Harmsen P., Rosengren A., Tsipogianni A., Wilhelmsen L. Risk factors for stroke in middle-aged men in Göteborg, Sweden. Stroke 1990, 21:223-229.
83. Hindfelt B., Nilsson O. Brain infarction in young adults (with particular reference to pathogenesis). Acta Neurol. Scand. 1977, 55:145-157.
84. Hong D.M., Mint J.J., Kim J.H., Sohn I.S., Lim T.W., Lim Y.J., Bahk J.H., Jeon Y. The effect of remote ischaemic preconditioning on myocardial injury in patients undergoing off-pump coronary artery bypass graft surgery. Anaesth. Intensive Care 2010, 38:924-929.
85. House A., Dennis M., Mogridge L., Hawton K., Warlow C. Life events and difficulties preceding stroke. J. Neurol. Neurosurg. Psychiatry 1990, 53:1024-1028.
86. Howells D.W., Porritt M.J., Rewell S.S., O'Collins V., Sena E.S., van der Worp H.B., Traystman R.J., Macleod M.R. Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2010, 30:1412-1431.
87. Htun P., Fateh-Moghadam S., Tomandl B., Handschu R., Klinger K., Stellos K., Garlichs C., Daniel W., Gawaz M. Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ischemia. Stroke 2006, 37:2283-2287.
88. Hu G., Sarti C., Jousilahti P., Peltonen M., Qiao Q., Antikainen R., Tuomilehto J. The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke 2005, 36:2538-2543.
89. Huang S.S., Wei F.C., Hung L.M. Ischemic preconditioning attenuates postischemic leukocyte-endothelial cell interactions: role of nitric oxide and protein kinase C. Circ. J. 2006, 70:1070-1075.
90. Johnston S.C. Ischemic preconditioning from transient ischemic attacks? Data from the Northern California TIA Study. Stroke 2004, 35:2680-2682.
91. Kamari Y., Shaish A., Vax E., Shemesh S., Kandel-Kfir M., Arbel Y., Olteanu S., Barshack I., Dotan S., Voronov E., et al. Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J. Hepatol. 2011, 55:1086-1094.
92. Kannel W.B., Wolf P.A., Verter J., McNamara P.M. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA 1970, 214:301-310.
93. Kaptoge S., Di Angelantonio E., Lowe G., Pepys M.B., Thompson S.G., Collins R., Danesh J. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375:132-140. Collaboration, E.R.F.
94. Kerr R., Stirling D., Ludlam C.A. Interleukin 6 and haemostasis. Br. J. Haematol. 2001, 115:3-12.
95. Kim Y.S., Immink R.V., Stok W.J., Karemaker J.M., Secher N.H., van Lieshout J.J. Dynamic cerebral autoregulatory capacity is affected early in type 2 diabetes. Clin. Sci. (Lond.) 2008, 115:255-262.
96. Kitagawa K., Matsumoto M., Tagaya M., Hata R., Ueda H., Niinobe M., Handa N., Fukunaga R., Kimura K., Mikoshiba K. 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 1990, 528:21-24.
97. Kloska S.P., Wintermark M., Engelhorn T., Fiebach J.B. Acute stroke magnetic resonance imaging: current status and future perspective. Neuroradiology 2010, 52:189-201.
98. Koenen R.R., von Hundelshausen P., Nesmelova I.V., Zernecke A., Liehn E.A., Sarabi A., Kramp B.K., Piccinini A.M., Paludan S.R., Kowalska M.A., et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat. Med. 2009, 15:97-103.
99. Kumari R., Willing L.B., Krady J.K., Vannucci S.J., Simpson I.A. Impaired wound healing after cerebral hypoxia-ischemia in the diabetic mouse. J. Cereb. Blood Flow Metab. 2007, 27:710-718.
100. Kumari R., Willing L.B., Patel S.D., Krady J.K., Zavadoski W.J., Gibbs E.M., Vannucci S.J., Simpson I.A. The PPAR-gamma agonist, darglitazone, restores acute inflammatory responses to cerebral hypoxia-ischemia in the diabetic ob/ob mouse. J. Cereb. Blood Flow Metab. 2010, 30:352-360.
101. Kunz A., Park L., Abe T., Gallo E.F., Anrather J., Zhou P., Iadecola C. Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen species. J. Neurosci. 2007, 27:7083-7093.
102. Kurukulasuriya L.R., Govindarajan G., Sowers J. Stroke prevention in diabetes and obesity. Expert. Rev. Cardiovasc. Ther. 2006, 4:487-502.
103. Lalancette-Hébert M., Gowing G., Simard A., Weng Y.C., Kriz J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 2007, 27:2596-2605.
104. Lam C.K., Yoo T., Hiner B., Liu Z., Grutzendler J. Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization. Nature 2010, 465:478-482.
105. Lambertsen K.L., Clausen B.H., Babcock A.A., Gregersen R., Fenger C., Nielsen H.H., Haugaard L.S., Wirenfeldt M., Nielsen M., Dagnaes-Hansen F., et al. Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J. Neurosci. 2009, 29:1319-1330.
106. Lastres-Becker I., Cartmell T., Molina-Holgado F. Endotoxin preconditioning protects neurones from in vitro ischemia: role of endogenous IL-1beta and TNF-alpha. J. Neuroimmunol. 2006, 173:108-116.
107. Lavallée P., Perchaud V., Gautier-Bertrand M., Grabli D., Amarenco P. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002, 33:513-518.
108. Lawes C.M., Bennett D.A., Feigin V.L., Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 2004, 35:776-785.
109. Lithner F., Asplund K., Eriksson S., Hägg E., Strand T., Wester P.O. Clinical characteristics in diabetic stroke patients. Diabete Metab. 1988, 14:15-19.
110. Lynch A.M., Walsh C., Delaney A., Nolan Y., Campbell V.A., Lynch M.A. Lipopolysaccharide-induced increase in signalling in hippocampus is abrogated by IL-10-a role for IL-1 beta?. J. Neurochem. 2004, 88:635-646.
111. Macko R.F., Ameriso S.F., Barndt R., Clough W., Weiner J.M., Fisher M. Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress. Stroke 1996, 27:1999-2004.
112. Madrigal J.L., Caso J.R., de Cristóbal J., Cárdenas A., Leza J.C., Lizasoain I., Lorenzo P., Moro M.A. Effect of subacute and chronic immobilisation stress on the outcome of permanent focal cerebral ischaemia in rats. Brain Res. 2003, 979:137-145.
113. Maier W., Altwegg L.A., Corti R., Gay S., Hersberger M., Maly F.E., Sütsch G., Roffi M., Neidhart M., Eberli F.R., et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 2005, 111:1355-1361.
114. Mangat R., Su J., Scott P.G., Russell J.C., Vine D.F., Proctor S.D. Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome. Biochem. Soc. Trans. 2007, 35:477-481.
115. Marriott H.M., Gascoyne K.A., Gowda R., Geary I., Nicklin M.J., Iannelli F., Pozzi G., Mitchell T.J., Whyte M.K., Sabroe I., et al. IL-1β regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intracellular cooperation between pulmonary epithelial cells and macrophages. Infect Immun. 2012, Mar 80(3):1140-1149. (Epub 2011 Dec 12).
116. Massberg S., Brand K., Grüner S., Page S., Müller E., Müller I., Bergmeier W., Richter T., Lorenz M., Konrad I., et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J. Exp. Med. 2002, 196:887-896.
117. Matsumoto M., Ishikawa S., Kajii E. Cumulative effects of weather on stroke incidence: a multi-community cohort study in Japan. J. Epidemiol. 2010, 20:136-142.
118. Matsuo Y., Onodera H., Shiga Y., Nakamura M., Ninomiya M., Kihara T., Kogure K. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke 1994, 25:1469-1475.
119. McCabe C., Gallagher L., Gsell W., Graham D., Dominiczak A.F., Macrae I.M. Differences in the evolution of the ischemic penumbra in stroke-prone spontaneously hypertensive and Wistar-Kyoto rats. Stroke 2009, 40:3864-3868.
120. McColl B., Rothwell N., Allan S. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J. Neurosci. 2007, 27:4403-4412.
121. McColl B.W., Rothwell N.J., Allan S.M. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J. Neurosci. 2007, 27:4403-4412.
122. McColl B., Rothwell N., Allan S. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci. 2008, 28:9451-9462.
123. McColl B., Allan S., Rothwell N. Systemic infection, inflammation and acute ischemic stroke. Neuroscience 2009, 158:1049-1061.
124. McColl B.W., Rose N., Robson F.H., Rothwell N.J., Lawrence C.B. Increased brain microvascular MMP-9 and incidence of haemorrhagic transformation in obese mice after experimental stroke. J. Cereb. Blood Flow Metab. 2010, 30:267-272.
125. McKellar G.E., McCarey D.W., Sattar N., McInnes I.B. Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat. Rev. Cardiol. 2009, 6:410-417.
126. Mellion B.T., Ignarro L.J., Ohlstein E.H., Pontecorvo E.G., Hyman A.L., Kadowitz P.J. Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981, 57:946-955.
127. Meng R., Li Z.Y., Ji X., Ding Y., Meng S., Wang X. Antithrombin III associated with fibrinogen predicts the risk of cerebral ischemic stroke. Clin. Neurol. Neurosurg. 2011, 113:380-386.
128. Moskowitz M.A., Lo E.H., Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010, 67:181-198.
129. Moutsopoulos N.M., Madianos P.N. Low-grade inflammation in chronic infectious diseases: paradigm of periodontal infections. Ann. N. Y. Acad. Sci. 2006, 1088:251-264.
130. Muhammad S., Haasbach E., Kotchourko M., Strigli A., Krenz A., Ridder D.A., Vogel A.B., Marti H.H., Al-Abed Y., Planz O., et al. Influenza virus infection aggravates stroke outcome. Stroke 2011, 42:783-791.
131. Murikinati S., Jüttler E., Keinert T., Ridder D.A., Muhammad S., Waibler Z., Ledent C., Zimmer A., Kalinke U., Schwaninger M. Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. FASEB J. 2010, 24:788-798.
132. O'Collins V.E., Macleod M.R., Donnan G.A., Horky L.L., van der Worp B.H., Howells D.W. 1,026 experimental treatments in acute stroke. Ann. Neurol. 2006, 59:467-477.
133. Olah M., Amor S., Brouwer N., Vinet J., Eggen B., Biber K., Boddeke H.W. Identification of a microglia phenotype supportive of remyelination. Glia 2012, 60:306-321.
134. Oppenheimer S.M., Hoffbrand B.I., Oswald G.A., Yudkin J.S. Diabetes mellitus and early mortality from stroke. Br. Med. J. (Clin. Res. Ed.) 1985, 291:1014-1015.
135. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-424.
136. Paganini-Hill A., Lozano E., Fischberg G., Perez Barreto M., Rajamani K., Ameriso S.F., Heseltine P.N., Fisher M. Infection and risk of ischemic stroke: differences among stroke subtypes. Stroke 2003, 34:452-457.
137. Panza J.A., Quyyumi A.A., Brush J.E., Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 1990, 323:22-27.
138. Patel J.V., Abraheem A., Dotsenko O., Creamer J., Gunning M., Hughes E.A., Lip G.Y. Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function. J. Intern. Med. 2008, 264:593-598.
139. Pedersen C.M., Cruden N.L., Schmidt M.R., Lau C., Bøtker H.E., Kharbanda R.K., Newby D.E. Remote ischemic preconditioning prevents systemic platelet activation associated with ischemia-reperfusion injury in humans. J. Thromb. Haemost. 2011, 9:404-407.
140. Pepine C.J. The impact of nitric oxide in cardiovascular medicine: untapped potential utility. Am. J. Med. 2009, 122:S10-S15.
141. Perry V.H., Anthony D.C., Bolton S.J., Brown H.C. The blood-brain barrier and the inflammatory response. Mol. Med. Today 1997, 3:335-341.
142. Perry V.H., Cunningham C., Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 2007, 7:161-167.
143. Pinteaux E., Parker L.C., Rothwell N.J., Luheshi G.N. Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J. Neurochem. 2002, 83:754-763.
144. Plaikner M., Peer A., Falkensammer G., Schmidauer C., Pechlaner C., Griesmacher A., Pachinger O., Mair J. Lack of association of soluble CD40 ligand with the presence of acute myocardial infarction or ischemic stroke in the emergency department. Clin. Chem. 2009, 55:175-178.
145. Plescia J., Altieri D.C. Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. Biochem. J. 1996, 319(Pt 3):873-879.
146. Pradillo J.M., Fernández-López D., García-Yébenes I., Sobrado M., Hurtado O., Moro M.A., Lizasoain I. Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning. J. Neurochem. 2009, 109:287-294.
147. Pradillo J.M., Denes A., Greenhalgh A.D., Boutin H., Drake C., McColl B.W., Barton E., Proctor S.D., Russell J.C., Rothwell N.J., et al. Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats. J Cereb Blood Flow Metab. 2012, Sep 32(9):1810-1819. (Epub 2012 Jul 11).
148. Prager M., Türel Z., Speidl W.S., Zorn G., Kaun C., Niessner A., Heinze G., Huk I., Maurer G., Huber K., et al. Chlamydia pneumoniae in carotid artery atherosclerosis: a comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals. Stroke 2002, 33:2756-2761.
149. Prentice R.L., Szatrowski T.P., Kato H., Mason M.W. Leukocyte counts and cerebrovascular disease. J. Chronic Dis. 1982, 35:703-714.
150. Pulsinelli W.A., Levy D.E., Sigsbee B., Scherer P., Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am. J. Med. 1983, 74:540-544.
151. Purkayastha S., Zhang G., Cai D. Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB. Nat. Med. 2011, 17:883-887.
152. Rahman I.A., Mascaro J.G., Steeds R.P., Frenneaux M.P., Nightingale P., Gosling P., Townsend P., Townend J.N., Green D., Bonser R.S. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?. Circulation 2010, 122:S53-S59.
153. Razinia T., Saver J.L., Liebeskind D.S., Ali L.K., Buck B., Ovbiagele B. Body mass index and hospital discharge outcomes after ischemic stroke. Arch. Neurol. 2007, 64:388-391.
154. Rewell S.S., Fernandez J.A., Cox S.F., Spratt N.J., Hogan L., Aleksoska E., van Raay L., Liberatore G.T., Batchelor P.E., Howells D.W. Inducing stroke in aged, hypertensive, diabetic rats. J. Cereb. Blood Flow Metab. 2010, 30:729-733.
155. Ritter L., Davidson L., Henry M., Davis-Gorman G., Morrison H., Frye J.B., Cohen Z., Chandler S., McDonagh P., Funk J.L. Exaggerated neutrophil-mediated reperfusion injury after ischemic stroke in a rodent model of type 2 diabetes. Microcirculation 2011, 18:552-561.
156. Rizzoni D., De Ciuceis C., Porteri E., Paiardi S., Boari G.E., Mortini P., Cornali C., Cenzato M., Rodella L.F., Borsani E., et al. Altered structure of small cerebral arteries in patients with essential hypertension. J. Hypertens. 2009, 27:838-845.
157. Ross R. Atherosclerosis is an inflammatory disease. Am. Heart J. 1999, 138:S419-S420.
158. Rozenberg I., Sluka S.H., Mocharla P., Hallenberg A., Rotzius P., Borén J., Kränkel N., Landmesser U., Borsig L., Lüscher T.F., et al. Deletion of L-selectin increases atherosclerosis development in ApoE-/- mice. PLoS One 2011, 6:e21675.
159. Ruggeri Z.M. Platelets in atherothrombosis. Nat. Med. 2002, 8:1227-1234.
160. Sattar N., Murray H.M., McConnachie A., Blauw G.J., Bollen E.L., Buckley B.M., Cobbe S.M., Ford I., Gaw A., Hyland M., et al. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation 2007, 115:981-989.
161. Schrör K., Braun M. Platelets as a source of vasoactive mediators. Stroke 1990, 21:IV32-IV35.
162. Shebuski R.J., Kilgore K.S. Role of inflammatory mediators in thrombogenesis. J. Pharmacol. Exp. Ther. 2002, 300:729-735.
163. Shin J.A., Park E.M., Choi J.S., Seo S.M., Kang J.L., Lee K.E., Cho S. Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex. J. Neuroimmunol. 2009, 217:14-19.
164. Singer G., Granger D.N. Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance. Microcirculation 2007, 14:375-387.
165. Slowik J., Wnuk M.A., Grzech K., Golenia A., Turaj W., Ferens A., Jurczak A., Chomyszyn-Gajewska M., Loster B., Slowik A. Periodontitis affects neurological deficit in acute stroke. J. Neurol. Sci. 2010, 297:82-84.
166. Smeeth L., Thomas S., Hall A., Hubbard R., Farrington P., Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N. Engl. J. Med. 2004, 351:2611-2618.
167. Sorce S., Bonnefont J., Julien S., Marq-Lin N., Rodriguez I., Dubois-Dauphin M., Krause K.H. Increased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5. Br. J. Pharmacol. 2010, 160:311-321.
168. Spencer S.J., Mouihate A., Pittman Q.J. Peripheral inflammation exacerbates damage after global ischemia independently of temperature and acute brain inflammation. Stroke 2007, 38:1570-1577.
169. Spera P.A., Ellison J.A., Feuerstein G.Z., Barone F.C. IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett. 1998, 251:189-192.
170. STAIR Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999, 30:2752-2758.
171. Stein P.D., Beemath A., Olson R.E. Obesity as a risk factor in venous thromboembolism. Am. J. Med. 2005, 118:978-980.
172. Suffee N., Richard B., Hlawaty H., Oudar O., Charnaux N., Sutton A. Angiogenic properties of the chemokine RANTES/CCL5. Biochem. Soc. Trans. 2011, 39:1649-1653.
173. Symmons D.P. Looking back: rheumatoid arthritis--aetiology, occurrence and mortality. Rheumatology (Oxford) 2005, 44(Suppl. 4):iv14-iv17.
174. Tagami M., Nara Y., Kubota A., Fujino H., Yamori Y. Ultrastructural changes in cerebral pericytes and astrocytes of stroke-prone spontaneously hypertensive rats. Stroke 1990, 21:1064-1071.
175. Tasaki K., Ruetzler C.A., Ohtsuki T., Martin D., Nawashiro H., Hallenbeck J.M. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 1997, 748:267-270.
176. Terao S., Yilmaz G., Stokes K.Y., Ishikawa M., Kawase T., Granger D.N. Inflammatory and injury responses to ischemic stroke in obese mice. Stroke 2008, 39:943-950.
177. Terao S., Yilmaz G., Stokes K.Y., Russell J., Ishikawa M., Kawase T., Granger D.N. Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion. Stroke 2008, 39:2560-2570.
178. Teunissen L.L., Rinkel G.J., Algra A., van Gijn J. Risk factors for subarachnoid hemorrhage: a systematic review. Stroke 1996, 27:544-549.
179. Thornton P., McColl B.W., Greenhalgh A., Denes A., Allan S.M., Rothwell N.J. Platelet interleukin-1alpha drives cerebrovascular inflammation. Blood 2010, 115:3632-3639.
180. Vandanmagsar B., Youm Y.H., Ravussin A., Galgani J.E., Stadler K., Mynatt R.L., Ravussin E., Stephens J.M., Dixit V.D. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011, 17:179-188.
181. Vinet J., van Weering H.R., Heinrich A., Kalin R.E., Wegner A., Brouwer N., Heppner F.L., van Rooijen N., Boddeke H.W., Biber K. Neuroprotective function for ramified microglia in hippocampal excitotoxicity. J. Neuroinflammation 2012, 9:27.
182. Virani S.S., Nambi V., Hoogeveen R., Wasserman B.A., Coresh J., Gonzalez F., Chambless L.E., Mosley T.H., Boerwinkle E., Ballantyne C.M. Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. Eur. Heart J. 2011, 32:459-468.
183. Walsh S.R., Sadat U., Boyle J.R., Tang T.Y., Lapsley M., Norden A.G., Gaunt M.E. Remote ischemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomized controlled trial. Vasc. Endovascular Surg. 2010, 44:334-340.
184. Wegener S., Gottschalk B., Jovanovic V., Knab R., Fiebach J.B., Schellinger P.D., Kucinski T., Jungehülsing G.J., Brunecker P., Müller B., et al. Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke 2004, 35:616-621.
185. Welsh P., Barber M., Langhorne P., Rumley A., Lowe G.D., Stott D.J. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Cerebrovasc. Dis. 2009, 27:247-253.
186. Wilhelmsen L., Svärdsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N. Engl. J. Med. 1984, 311:501-505.
187. Woo J., Lam C.W., Kay R., Wong A.H., Teoh R., Nicholls M.G. The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch. Neurol. 1990, 47:1174-1177.
188. Yaegashi M., Jean R., Zuriqat M., Noack S., Homel P. Outcome of morbid obesity in the intensive care unit. J. Intensive Care Med. 2005, 20:147-154.
189. Yamagata K. Pathological alterations of astrocytes in stroke-prone spontaneously hypertensive rats under ischemic conditions. Neurochem. Int. 2012, 60:91-98.
190. Zeller J.A., Lenz A., Eschenfelder C.C., Zunker P., Deuschl G. Platelet-leukocyte interaction and platelet activation in acute stroke with and without preceding infection. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1519-1523.
191. Zernecke A., Liehn E.A., Gao J.L., Kuziel W.A., Murphy P.M., Weber C. Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10. Blood 2006, 107:4240-4243.
192. Zhang W., Chen Y., Liu P., Chen J., Song L., Tang Y., Wang Y., Liu J., Hu F.B., Hui R. Variants on chromosome 9p21.3 correlated with ANRIL expression contribute to stroke risk and recurrence in a large prospective stroke population. Stroke 2011, Jan 43(1):14-21. (Epub 2011 Oct 27).
193. Zhao B.Q., Tejima E., Lo E.H. Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke. Stroke 2007, 38:748-752.
194. Zou M.H., Cohen R., Ullrich V. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 2004, 11:89-97.